An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia
OptimaMed
The OptimaMed Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia: Results From a Quasi-experimental Intervention Study
1 other identifier
interventional
44
1 country
1
Brief Summary
An education intervention to promote medication reviews and interdisciplinary discussions within long-term care facilities with the aim of improving medication regimen among residents with severe dementia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 16, 2018
CompletedFirst Posted
Study publicly available on registry
May 29, 2018
CompletedJune 1, 2018
May 1, 2018
7 months
May 16, 2018
May 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication regimen
Active prescriptions
Four months post intervention
Secondary Outcomes (2)
Level of pain
Four months post intervention
Level of agitation
Four months post intervention
Study Arms (2)
Pre-intervention
NO INTERVENTIONUsual care
Post-intervention
EXPERIMENTALOne 90-minute interdisciplinary knowledge exchange including the provision of a validated list of appropriate and inappropriate medications for severe dementia long-term care residents.
Interventions
Eligibility Criteria
You may qualify if:
- diagnosis of dementia of any etiology
- severe dementia
You may not qualify if:
- admission less than 2 months before intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Quebec-Universite Lavallead
- McGill Universitycollaborator
- Université de Montréalcollaborator
- Université de Sherbrookecollaborator
- Fonds de la Recherche en Santé du Québeccollaborator
Study Sites (1)
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Québec, Canada
Related Publications (1)
Kroger E, Wilchesky M, Marcotte M, Voyer P, Morin M, Champoux N, Monette J, Aubin M, Durand PJ, Verreault R, Arcand M. Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention. J Am Med Dir Assoc. 2015 Jul 1;16(7):629.e1-17. doi: 10.1016/j.jamda.2015.04.002. Epub 2015 May 13.
PMID: 25979776BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edeltraut Kröger, Ph.D.
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- It was unlikely that participants could foresee whether or when their medications have been reviewed or modified.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct professor
Study Record Dates
First Submitted
May 16, 2018
First Posted
May 29, 2018
Study Start
March 1, 2014
Primary Completion
October 1, 2014
Study Completion
December 1, 2015
Last Updated
June 1, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share